Epidemiologic Profile of Thyroid Disorders in a Tertiary Care Hospital, a Five Years Analysis

Thyroid disorders OPD patiesnt

  • Asma Nafisa Department of Pathlogy,Benazir Bhutto Hospital,Rawalpindi
  • Nadeem Ikram professor of pathology Rawal medical college
  • Soffia Khursheed consultant histopathologist Benazir Bhutto hospital Rawalpindi
  • Rabia Anjum consultant microbiologist Benazir Bhutto Hospital Rawalpindia
  • Naeem Akhtar professor of pathology Rawalpindi Medical university
Keywords: Epidemiology, Thyroid dysfunction, TSH, T3, T4, iodized salt, Pakistan


Background: Thyroid disorders are the most common endocrine ailments encountered in clinical practice.

 Objective: To determine the frequency of thyroid disorders in patients presented for thyroid dysfunction at the Department of Pathology, Benazir Bhutto Hospital Rawalpindi.

 Study Design: Cross-sectional analytical study.

Patients and Methods:  Patients who underwent thyroid function tests were enrolled in the study Thyroid function tests were performed on a fully automated Chemiluminescence Chemistry Analyzer. Graph Pad Prism version 7 and SPSS version 25 were used for statistical analysis of the data.

Results: Out of 2856 patients, 81.9% were females and 18.1% were males. The mean age of the participants was 38.12 ± 14.51 years and the median was 35(13-96).   Overall, 1951 (68.3%) of the subjects were euthyroid, 343(12.0%) had subclinical hyperthyroidism, 200 (7.0%) had subclinical hypothyroidism, 192(6.7%) had overt hyperthyroidism and 168 (5.9%) had overt hypothyroidism. Females have a significantly high percentage of thyroid disorders as compared to males(χ2 =0.976 p =0.027). The major age group 798(27.9 %) tested for thyroid dysfunction suspicion was 24 to 33 years followed by 34-43 (22.9%).

Conclusions: The thyroid dysfunction prevalence was higher in females than males. An upward trend in the frequency of thyroid dysfunction was observed with increasing age.  Subclinical hyperthyroidism was the commonest abnormality followed by subclinical hypothyroidism overt hyperthyroidism and overt hypothyroidism.

Keywords: Epidemiology, Thyroid dysfunction, TSH, T3, T4, iodized salt, Pakistan


1. Gaberšček S, Zaletel K. Epidemiological trends of iodine-related thyroid disorders: an example from Slovenia. Archives of Industrial Hygiene and Toxicology. 2016;67(2):93-8. DOI: 10.1515/aiht-2016-67-2725
2. Rodríguez Cortés JM, Mendieta Zerón H. Genetics of thyroid disorders. 2019. DOI: 10.2478/folmed-2018-0078
3. Pirahanchi Y, Tariq MA, Jialal I. Physiology, thyroid. StatPearls [Internet]. 2020.
4. Hadlow NC, Rothacker KM, Wardrop R, Brown SJ, Lim EM, Walsh JP. The relationship between TSH and free T4 in a large population is complex and nonlinear and differs by age and sex. The Journal of Clinical Endocrinology & Metabolism. 2013;98(7):2936-43. DOI.org/10.1210/jc.2012-4223

5. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-421. DOI: 10.1089/thy.2016.0229

6. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA guideline: management of subclinical hypothyroidism. European thyroid journal. 2013;2(4):215-28. DOI: 10.1159/000356507
7. Khan A, Akhter S, Siddiqui MM, Nawab G, Khattak KN. Continuous use of iodized salt may cause thyrotoxicosis in plain areas of North West Frontier Province (NWFP) of Pakistan. J Med Sci. 2003;3(5-6):423-28. DOI:10.3923/jms.2002.89 94
8. Sarwar S. Iodized salt: a risk factor for hyperthyroidism. Journal of Rawalpindi Medical College. 2013;17(2):284-7.
9. Song R-h, Wang B, Yao Q-m, Li Q, Jia X, Zhang J-a. The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis. Frontiers in immunology. 2019;10:2349. DOI: 10.3389/fimmu.2019.02349

10. Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. Journal of thyroid research. 2011;2011. DOI: 10.4061/2011/439463
11. Berta E, Lengyel I, Halmi S, Zrínyi M, Erdei A, Harangi M, et al. Hypertension in thyroid disorders. Frontiers in endocrinology. 2019;10:482. DOI:org/10.3389/fendo.2019.00482
12. Li H, Zeng R, Liao Y, Fu M, Zhang H, Wang L, et al. Prevalence and Risk Factors of Left Ventricular Diastolic Dysfunction in Patients With Hyperthyroidism. Frontiers in Endocrinology. 2021;11:1022. DOI: 10.3389/fendo.2020.605712

13. Trokoudes KM, Skordis N, Picolos MK. Infertility and thyroid disorders. Current Opinion in Obstetrics and Gynecology. 2006;18(4):446-51. DOI: 10.1097/01.gco.0000233941.89919.31
14. Shah N, Ursani TJ, Shah NA, Raza HMZ. Prevalence and Manifestations of Hypothyroidism among Population of Hyderabad, Sindh, Pakistan. Pure and Applied Biology. Vol. 10, Issue 3, pp668-675. 2020. DOI: org/10.19045/bspab.2021.100069
15. Shekhar S, Kumari S, Prasad A, Tripathy S. Prevalence of thyroid disorders in rohtas district of bihar: a hospital based study. J Med Sci Clin Res. 2018;6(4):590-7. DOI: org/10.18535/jmscr/v6i4.97
16. Deokar P, Nagdeote A, Lanje M, Basutkar D. Prevalence of thyroid disorders in a tertiary care center. International Journal of Current Research and Review. 2016;8(9):26.
17. Valdes S, Maldonado-Araque C, Lago-Sampedro A, Lillo JA, Garcia-Fuentes E, Perez-Valero V, et al. Population-based national prevalence of thyroid dysfunction in Spain and associated factors: Di@ bet. es Study. Thyroid. 2017;27(2):156-66. DOI: 10.1089/thy.2016.0353
18. Naz N, Rizvi S, Sadiq Z. Assessment of thyroid hormone levels and thyroid disorders: A case study from Gujranwala, Pakistan. Pakistan journal of pharmaceutical sciences. 2017;30(4):1245-1249
19. Alam Khan V, Khan MA, Akhtar S. Thyroid disorders, etiology and prevalence. J Med Sci. 2002;2(2):89-94.
20. Lu Y, Li J. Estrogen and thyroid diseases: an update. Minerva medica. 2016;107(4):239-44.
21. Alam JM, Mahmood SR, Baig JA, Sultana I. Assessment of Sub-clinical hypothyroidism and Hyperthyroidism status in adult patients. Pak J Pharmacol. 2010;27(1):49-60.
22. Khan MA, Ahsan T, Rehman UL, Jabeen R, Farouq S. Subclinical Hypothyroidism: Frequency, clinical presentations and treatment indications. Pakistan journal of medical sciences. 2017;33(4):818. DOI: 10.12669/pjms.334.12921
23. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of internal medicine. 2000;160(4):526-34. DOI: 10.1001/archinte.160.4.526.
24. Cooper DS, Biondi B. Subclinical thyroid disease. The Lancet. 2012;379(9821):1142-54. DOI: 10.1016/S0140-6736(11)60276-6
25. Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. Jama. 2019;322(2):153-60. DOI: 10.1001/jama.2019.9052
26. Surks MI, Boucai L. Age-and race-based serum thyrotropin reference limits. The Journal of Clinical Endocrinology & Metabolism. 2010;95(2):496-502. DOI:org/10.1089/thy.2010.0092
27. Akhter S, Khan A, Siddiqui MM, Nawab G. Frequencies of thyroid problems in different age, sex and seasons. J Med Sci. 2001;1:153-6. DOI: 10.3923/jms.2001.153.156
28. Vargas-Uricoechea H, Pinzón-Fernández MV, Bastidas-Sánchez BE, Jojoa-Tobar E, Ramírez-Bejarano LE, Murillo-Palacios J. Iodine Status in the Colombian Population and the Impact of Universal Salt Iodization: A Double-Edged Sword? Journal of nutrition and metabolism. 2019;2019. DOI: 10.1155/2019/6239243
29. Petersen M, Knudsen N, Carlé A, Andersen S, Jørgensen T, Perrild H, et al. Thyrotoxicosis after iodine fortification. A 21‐year Danish population‐based study. Clinical endocrinology. 2018;89(3):360-6. DOI:10.1111/cen.13751
30. Lee SY, Rhee CM, Leung AM, Braverman LE, Brent GA, Pearce EN. A review: radiographic iodinated contrast media-induced thyroid dysfunction. The Journal of Clinical Endocrinology & Metabolism. 2015;100(2):376-83. DOI: 10.1210/jc.2014-3292
31. Connolly R. An increase in thyrotoxicosis in southern Tasmania after an increase in dietary iodine. Medical Journal of Australia. 1971;1(24):1268-71. DOI:10.1530/eje.0.1320546
32. Baltisberger BL, Minder CE, Bürgi H. Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. European Journal of Endocrinology. 1995;132(5):546-9. DOI: 10.1530/eje.0.1320546
33. Calsolaro V, Pasqualetti G, Niccolai F, Caraccio N, Monzani F. Thyroid disrupting chemicals. International journal of molecular sciences. 2017;18(12):2583. DOI: 10.3390/ijms18122583
34. Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, et al. Thyroid hormones and cardiovascular function and diseases. Journal of the American College of Cardiology. 2018;71(16):1781-96. DOI: 10.1016/j.jacc.2018.02.045

35. Unuane D, Velkeniers B. Impact of thyroid disease on fertility and assisted conception. Best Practice & Research Clinical Endocrinology & Metabolism. 2020:101378. DOI: 10.1016/j.beem.2020.101378
How to Cite
Nafisa A, Ikram N, Khursheed S, Anjum R, Akhtar N. Epidemiologic Profile of Thyroid Disorders in a Tertiary Care Hospital, a Five Years Analysis. JRMC [Internet]. 31Dec.2021 [cited 21Jan.2022];25(4). Available from: https://journalrmc.com/index.php/JRMC/article/view/1682

Most read articles by the same author(s)